Ralf Brandt

4.8k citations

27 papers · 4.0k indexed · 1 hit paper · h-index 18

Impact in

Oncology top 1%
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Cancer Cells and Metastasis
Pulmonary and Respiratory Medicine top 2%
- Lung Cancer Treatments and Mutations

Papers in

Oncology 17
- HER2/EGFR in Cancer Research 10
- Cancer Cells and Metastasis 3
- Cancer survivorship and care 3
Genetics 8
- Estrogen and related hormone effects 4
- Animal Genetics and Reproduction 3

Co-authors: Nicola Normanno Fortunato Ciardiello David S. Salomon Edward Hammond Keith Dredge Heidi A. Lane Paul M.J. McSheehy Markus Wartmann
Journals: Cancer Research (3 papers)British Journal of Cancer (2 papers)International Journal of Oncology (2 papers)Journal of Biological Chemistry (2 papers)Breast Cancer Research and Treatment (2 papers)
Partner nations: United States Germany Italy

In The Last Decade

Ralf Brandt

27 papers receiving 3.9k citations

Hit Papers

align trajectories log scale

Epidermal growth factor-related peptides and their receptors in human malignancies 1995 · 2.2k citations

Peers

Countries citing papers authored by Ralf Brandt

Since Specialization

Citations

This map shows the geographic impact of Ralf Brandt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralf Brandt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralf Brandt more than expected).

Fields of papers citing papers by Ralf Brandt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralf Brandt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralf Brandt. The network helps show where Ralf Brandt may publish in the future.

Co-authors

The 25 scholars most cited alongside Ralf Brandt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ralf Brandt Line = papers co-authored together Ralf Brandt links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Conceptual development of an intensive exercise program for glioma patients (ActiNO): summary of clinical experience Journal of Neuro-Oncology ·Johanna Jost, Michael Müther, Ralf Brandt, Ugur Altuner, Lars Lemcke, Walter Stummer, Klaus Völker, Rainer Wiewrodt, Dorothee Wiewrodt	2023	2
2	Feasibility, Safety and Effects of a One-Week, Ski-Based Exercise Intervention in Brain Tumor Patients and Their Relatives: A Pilot Study Journal of Clinical Medicine ·Fabian M. Troschel, Christian Ramroth, Lars Lemcke, Jens Clasing, Amelie S. Troschel, Martin Dugas, Walter Stummer, Rainer Wiewrodt, Ralf Brandt, Dorothee Wiewrodt	2020	6
3	A formulation of pancreatic pro-enzymes provides potent anti-tumour efficacy: a pilot study focused on pancreatic and ovarian cancer Scientific Reports ·Macarena Perán, Elena López‐Ruiz, María Ángel García, Shorena Nadaraia-Hoke, Ralf Brandt, Juan Antonio Marchal, Julian Kenyon	2017	8
4	PG545, a Heparan Sulfate Mimetic, Reduces Heparanase Expression In Vivo, Blocks Spontaneous Metastases and Enhances Overall Survival in the 4T1 Breast Carcinoma Model PLoS ONE ·Edward Hammond, Ralf Brandt, Keith Dredge	2012	57
5	PG545, a dual heparanase and angiogenesis inhibitor, induces potent anti-tumour and anti-metastatic efficacy in preclinical models British Journal of Cancer ·Keith Dredge, Edward Hammond, Paul Handley, Thomas J. Gonda, Maree T. Smith, Christina Vincent, Ralf Brandt, Vito Ferro, Ian Bytheway	2011	147
6	R428, a Selective Small Molecule Inhibitor of Axl Kinase, Blocks Tumor Spread and Prolongs Survival in Models of Metastatic Breast Cancer Cancer Research ·Sacha J. Holland, Alison Pan, Christian Franci, Yuanming Hu, Betty Chang, Weiqun Li, Matt Duan, Allan Torneros, Jiaxin Yu, Thilo J. Heckrodt, Jing Zhang, Pingyu Ding, Ayodele Apatira, Joanne Chua, Ralf Brandt, Polly Pine, Dane A. Goff, Rajinder Singh, Donald G. Payan, Yasumichi Hitoshi	2010	429
7	Evaluation of the mTOR inhibitor, everolimus, in combination with cytotoxic antitumor agents using human tumor models in vitro and in vivo Anti-Cancer Drugs ·Terry O’Reilly, Paul M.J. McSheehy, Markus Wartmann, Peter Lassota, Ralf Brandt, Heidi A. Lane	2010	57
8	AEE788 Cancer Research ·Peter Traxler, Peter R. Allegrini, Ralf Brandt, Josef Brueggen, Robert Cozens, Doriano Fabbro, Konstantina Grosios, Heidi A. Lane, Paul M.J. McSheehy, Jürgen Mestan, Thomas Meyer, Careen K. Tang, Markus Wartmann, Jeanette M. Wood, Giorgio Caravatti	2004	268
9	Mammary glands reconstituted with Neu/ErbB2 transformed HC11 cells provide a novel orthotopic tumor model for testing anti-cancer agents Oncogene ·Ralf Brandt, Agnes M-L Wong, Nancy E. Hynes	2001	39
10	Mammary gland specific hEGF receptor transgene expression induces neoplasia and inhibits differentiation Oncogene ·Ralf Brandt, Ralf Eisenbrandt, Frauke Leenders, W Zschiesche, Bert Binas, Carola Juergensen, Franz Theuring	2000	53
11	Growth Inhibitors for Mammary Epithelial Cells Progress in molecular and subcellular biology ·Ralf Brandt, Andreas D. Ebert	1998	3
12	Cripto Enhances the Tyrosine Phosphorylation of Shc and Activates Mitogen-activated Protein Kinase (MAPK) in Mammary Epithelial Cells Journal of Biological Chemistry ·Subha Kannan, Marta De Santis, M. Lohmeyer, Jean‐Pierre David, Gilbert H. Smith, Nancy E. Hynes, Masaharu Seno, Ralf Brandt, Caterina Bianco, Graziella Persico, Nicholas Kenney, Nicola Normanno, Isabel Martínez-Lacaci, Fortunato Ciardiello, David F. Stern, William J. Gullick, David S. Salomon	1997	87
13	Epidermal growth factor-related peptides and their receptors in human malignancies Critical Reviews in Oncology/Hematology ·David S. Salomon, Ralf Brandt, Fortunato Ciardiello, Nicola Normanno Hit paper breakdown →	1995	2242
14	The role of amphiregulin in breast cancer Breast Cancer Research and Treatment ·David S. Salomon, Nicola Normanno, Fortunato Ciardiello, Ralf Brandt, M. Shoyab, George J. Todaro	1995	52
15	Expression of transforming growth factor α, amphiregulin and cripto-1 in human breast carcinomas British Journal of Cancer ·C-F Qi, D S Liscia, Nicola Normanno, G Merlo, GR Johnson, WJ Gullick, Fortunato Ciardiello, Toshiaki Saeki, Ralf Brandt, N Kim	1994	105
16	Amphiregulin as an autocrine growth factor for c-Ha-ras- and c-erbB-2-transformed human mammary epithelial cells. Proceedings of the National Academy of Sciences ·Nicola Normanno, Mouna P. Selvam, Chen Feng Qi, Toshiaki Saeki, G R Johnson, N Kim, Fortunato Ciardiello, M. Shoyab, Gregory D. Plowman, Ralf Brandt	1994	87
17	Epidermal growth factor-related peptides in the pathogenesis of human breast cancer Breast Cancer Research and Treatment ·Nicola Normanno, Fortunato Ciardiello, Ralf Brandt, David S. Salomon	1994	90
18	EXPRESSION OF AMPHIREGULIN, CRIPTO-1, AND HEREGULIN-ALPHA IN HUMAN BREAST-CANCER CELLS International Journal of Oncology ·Nicola Normanno, C-F Qi, WJ Gullick, Graziella Persico, Yosef Yarden, DZ WEN, Gregory D. Plowman, Nicholas Kenney, G R Johnson, N. Kim, Ralf Brandt, Isabel Martínez-Lacaci, RB DICKSON, DS SALOMON	1993	55
19	Purification of a mammary-derived growth inhibitor (MDGI) related polypedptide expressed during pregnancy Biochemical and Biophysical Research Communications ·Ralf Brandt, Richard Grosse	1992	5
20	A 13-kilodalton protein purified from milk fat globule membranes is closely related to a mammary-derived growth inhibitor Biochemistry ·Ralf Brandt, Maren Pepperle, Albrecht Otto, Regine Kraft, Frank D. Boehmer, Richard Grosse	1988	46

About Ralf Brandt

Ralf Brandt is a scholar working on Oncology, Genetics, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Cell Biology, having authored 27 papers that have together received 4.0k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (10 papers), Glycosylation and Glycoproteins Research (5 papers), Estrogen and related hormone effects (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Cancer Cells and Metastasis (3 papers), Angiogenesis and VEGF in Cancer (3 papers), Cancer survivorship and care (3 papers) and Animal Genetics and Reproduction (3 papers). The work is most often cited by research in Oncology (2.5k citations), Pulmonary and Respiratory Medicine (1.1k citations), Radiology, Nuclear Medicine and Imaging (632 citations), Molecular Biology (1.9k citations) and Cancer Research (381 citations). Ralf Brandt has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include Nicola Normanno, Fortunato Ciardiello, David S. Salomon, Edward Hammond, Keith Dredge, Heidi A. Lane, Paul M.J. McSheehy, Markus Wartmann, Alison Pan and Christian Franci. Their work appears in journals such as Cancer Research, British Journal of Cancer, International Journal of Oncology, Journal of Biological Chemistry and Breast Cancer Research and Treatment.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact